Asian stock markets decline after a report by the Financial Times mentioned draft documents accidentally published by the World Health Organization suggesting Gilead Sciences' antiviral drug, Remdesivir, had failed to help severely ill COVID-19 patients in its first clinical trial. Gilead said the findings were inconclusive because the study conducted in China was terminated early.
